The diminution of the ASB2 gene proved deleterious in DLBCL cell lines, precipitating the inhibition of NF‐κB through the concurrent downregulation of RelB and the augmentation of IκBα. This evidence concerns the gene NFKBIA and diffuse large B-cell lymphoma.